Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion type Assertion NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_head.
- NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion description "[Three of five candidate vulnerability genes (RASD2, APOL5, MYH9, EIF3S7, and CACNG2), which had marginally significant associations with schizophrenia, had significant associations with schizophrenic patients who did not have deficits in sustained attention on the undegraded CPT (RASD2 gene SNP rs736212; p = .0008 with single locus analysis) and the degraded CPT (MYH9 gene haplotype 1-1-1-1 of SNP rs3752463 - rs1557540 - rs713839 - rs739097; p = .0059 with haplotype analysis).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_provenance.
- NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion evidence source_evidence_literature NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_provenance.
- NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion SIO_000772 18571626 NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_provenance.
- NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion wasDerivedFrom gad-20150221 NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_provenance.
- NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_assertion wasGeneratedBy ECO_0000203 NP125078.RAKF750GHOEe2hsWNoxVP-eKzRlaLT-su7E8XP_T9Cmco130_provenance.